Skip to main content
Erschienen in: International Journal of Legal Medicine 4/2016

16.05.2016 | Original Article

Dityrosine as a marker of acute myocardial infarction? Experiments with the isolated Langendorff heart

verfasst von: F. Mayer, M. Falk, R. Huhn, F. Behmenburg, S. Ritz-Timme

Erschienen in: International Journal of Legal Medicine | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

The isolated Langendorff heart was used to evaluate dityrosine as a marker of acute myocardial infarctions. The animal model allowed the generation of local infarctions with defined survival times, as well as infarctions with and without reperfusion. The results showed that dityrosine, at least under the conditions of the animal model, occurs very shortly after early ischemia and infarctions, since positive staining results were already obtained after a survival time of only 5 min. Furthermore, it could be proved that the occurrence of dityrosine does not depend on a reperfusion of the ischemic muscle area and that there are no differences in the staining patterns of infarctions with and without reperfusion. Positive staining results for dityrosine in control hearts without infarctions had to be considered when evaluating the tissue samples of the study hearts. In part, the positive staining results of the control hearts seemed to be an artefact of the Langendorff system, easily identifiable by a distinctive staining pattern. Positive staining results in tissue samples of hearts that suffered from arrhythmia on the other hand implied that the occurrence of dityrosine is not specific for myocardial infarctions. Taking into account the results of previous works on human tissue samples, however, these findings did not question the use of dityrosine as a diagnostic tool; they simply showed that myocardial damage due to oxidative stress might occur under various pathologic conditions.
Literatur
1.
Zurück zum Zitat Bell RM, Mocanu MM, Yellon DM (2011) Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol 50:940–950CrossRef Bell RM, Mocanu MM, Yellon DM (2011) Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol 50:940–950CrossRef
2.
Zurück zum Zitat Bi H, Yang Y, Huang J, Li Y, Ma C, Cong B (2013) Immunohistochemical detection of S100A1 in the post-mortem diagnosis of acute myocardial infarction. Diagnostic Pathol 8:84–91CrossRef Bi H, Yang Y, Huang J, Li Y, Ma C, Cong B (2013) Immunohistochemical detection of S100A1 in the post-mortem diagnosis of acute myocardial infarction. Diagnostic Pathol 8:84–91CrossRef
3.
Zurück zum Zitat Bolli R, Marban E (1999) Molecular and cellular mechanisms of myocardial stunning. Phyiol Rev 79:609–634CrossRef Bolli R, Marban E (1999) Molecular and cellular mechanisms of myocardial stunning. Phyiol Rev 79:609–634CrossRef
4.
Zurück zum Zitat Brinkmann B, Sepulchre MA, Fechner G (1993) The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damage. Int J Leg Med 106:135–141CrossRef Brinkmann B, Sepulchre MA, Fechner G (1993) The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damage. Int J Leg Med 106:135–141CrossRef
5.
Zurück zum Zitat Carden DL, Granger DN (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190:255–266CrossRef Carden DL, Granger DN (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190:255–266CrossRef
6.
Zurück zum Zitat Cascells W, Kimura H, Sanchez JA, Yu ZX, Ferrans VJ (1990) Immunohistochemical study of fibronectin in experimental myocardial infarction. Am J Pathol 137:801–810 Cascells W, Kimura H, Sanchez JA, Yu ZX, Ferrans VJ (1990) Immunohistochemical study of fibronectin in experimental myocardial infarction. Am J Pathol 137:801–810
7.
Zurück zum Zitat Davies MJ (2005) The oxidative environment and protein damage. Biochem Biophys Acta 1703:93–109PubMed Davies MJ (2005) The oxidative environment and protein damage. Biochem Biophys Acta 1703:93–109PubMed
8.
Zurück zum Zitat De Leiris J, Harding DP, Pestre S (1984) The isolated perfused rat heart: a model for studying myocardial hypoxia or ischemia. Basic Res Cardiol 79:313–321CrossRef De Leiris J, Harding DP, Pestre S (1984) The isolated perfused rat heart: a model for studying myocardial hypoxia or ischemia. Basic Res Cardiol 79:313–321CrossRef
9.
Zurück zum Zitat Ferrera R, Benhabbouche S, Bopassa JC, Li B, Ovize M (2009) One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model. Cardiovasc Drugs Ther 23:327–331CrossRef Ferrera R, Benhabbouche S, Bopassa JC, Li B, Ovize M (2009) One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model. Cardiovasc Drugs Ther 23:327–331CrossRef
10.
Zurück zum Zitat Fischbein MC, Wang T, Matijasevic M, Hong L, Apple FS (2003) Myocardial tissue troponins T and I—an immunohistochemical study in experimental models of myocardial ischemia. Cardiovasc Pathol 12:65–71CrossRef Fischbein MC, Wang T, Matijasevic M, Hong L, Apple FS (2003) Myocardial tissue troponins T and I—an immunohistochemical study in experimental models of myocardial ischemia. Cardiovasc Pathol 12:65–71CrossRef
11.
Zurück zum Zitat Giulivi C, Traaseth NJ, Davies KJA (2003) Tyrosine oxidation products: analysis and biological relevance. Amino Acids 25:227–232CrossRef Giulivi C, Traaseth NJ, Davies KJA (2003) Tyrosine oxidation products: analysis and biological relevance. Amino Acids 25:227–232CrossRef
12.
Zurück zum Zitat Johns TNP, Olson BJ (1954) Experimental myocardial infarction. Ann Surg 140:675–682CrossRef Johns TNP, Olson BJ (1954) Experimental myocardial infarction. Ann Surg 140:675–682CrossRef
13.
Zurück zum Zitat Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL (2001) Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging and heart failure. J Mol Call Cardiol 33:1065–1089CrossRef Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL (2001) Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging and heart failure. J Mol Call Cardiol 33:1065–1089CrossRef
14.
Zurück zum Zitat Mayer F, Pröpper S, Ritz-Timme S (2014) Dityrosine, a protein product of oxidative stress, as a possible maker of acute myocardial infarctions. Int J Legal Med 128:787–794CrossRef Mayer F, Pröpper S, Ritz-Timme S (2014) Dityrosine, a protein product of oxidative stress, as a possible maker of acute myocardial infarctions. Int J Legal Med 128:787–794CrossRef
15.
Zurück zum Zitat Meng X, Ming M, Wang E (2006) Heart fatty acid binding protein as a marker for post-mortem detection of early myocardial damage. For Sci Int 160:11–16 Meng X, Ming M, Wang E (2006) Heart fatty acid binding protein as a marker for post-mortem detection of early myocardial damage. For Sci Int 160:11–16
16.
Zurück zum Zitat Ortmann C, Pfeiffer H, Brinkmann B (2000) A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 113:215–220CrossRef Ortmann C, Pfeiffer H, Brinkmann B (2000) A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 113:215–220CrossRef
17.
Zurück zum Zitat Perrelli MG, Pagliaro P, Penna C (2011) Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol 3:186–200CrossRef Perrelli MG, Pagliaro P, Penna C (2011) Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol 3:186–200CrossRef
18.
Zurück zum Zitat Raedschelders K, Ansley DM, Chen DDY (2012) The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133:230–255CrossRef Raedschelders K, Ansley DM, Chen DDY (2012) The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133:230–255CrossRef
19.
Zurück zum Zitat Schwarz ER, Somoano Y, Hale SL, Kloner RA (2000) What is the required reperfusion period for assessment of myocardial infarct size using Triphenyltetrazolium chloride staining in the rat? J Thromb Thrombolysis 10:181–187CrossRef Schwarz ER, Somoano Y, Hale SL, Kloner RA (2000) What is the required reperfusion period for assessment of myocardial infarct size using Triphenyltetrazolium chloride staining in the rat? J Thromb Thrombolysis 10:181–187CrossRef
20.
Zurück zum Zitat Solaini G, Harris DA (2005) Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J 390:377–394CrossRef Solaini G, Harris DA (2005) Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J 390:377–394CrossRef
Metadaten
Titel
Dityrosine as a marker of acute myocardial infarction? Experiments with the isolated Langendorff heart
verfasst von
F. Mayer
M. Falk
R. Huhn
F. Behmenburg
S. Ritz-Timme
Publikationsdatum
16.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 4/2016
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-016-1376-6

Weitere Artikel der Ausgabe 4/2016

International Journal of Legal Medicine 4/2016 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …